RHENMAN & PARTNERS ASSET MANAGEMENT AB – Alnylam Pharmaceuticals, Inc. Transaction History
RHENMAN & PARTNERS ASSET MANAGEMENT AB portfolio value:
$15.54M
portfolio value
RHENMAN & PARTNERS ASSET MANAGEMENT AB quarter portfolio value change:
+37.24%
quarter
Alnylam Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | 4.60M | $200.16 | 75K | |
| Q2 2022 | share | Decrease | -42.31% | -55K shares | -10.28M | $145.85 | 75K |
| Q1 2022 | share | Decrease | -25.71% | -45K shares | -8.70M | $163.29 | 130K |
| Q4 2021 | share | Increase | +75.00% | 75K shares | 11.04M | $171.03 | 175K |
| Q3 2021 | share | Decrease | -25.93% | -35K shares | -4.00M | $188.81 | 100K |
| Q2 2021 | share | 0.00% | 0 shares | 3.82M | $169.52 | 135K | |
| Q1 2021 | share | Increase | +20.86% | 23.3K shares | 4.54M | $141.19 | 135K |
| Q4 2020 | share | Increase | +11.70% | 11.7K shares | -42K | $129.97 | 111.7K |
| Q3 2020 | share | Increase | +61.04% | 37.90K shares | 5.36M | $145.6 | 100K |
| Q2 2020 | share | Decrease | -22.38% | -17.90K shares | 489K | $148.11 | 62.09K |
| Q1 2020 | share | Increase | +31.76% | 19.28K shares | 1.71M | $108.85 | 80K |
| Q4 2019 | share | Decrease | -12.01% | -8.28K shares | 1.44M | $115.17 | 60.71K |
| Q3 2019 | share | Decrease | -15.39% | -12.55K shares | -368K | $80.42 | 69K |
| Q2 2019 | share | Decrease | -10.92% | -10K shares | -2.63M | $72.56 | 81.55K |
| Q1 2019 | share | Decrease | -17.93% | -20K shares | 422K | $93.45 | 91.55K |
| Q4 2018 | share | Decrease | -35.13% | -60.4K shares | -6.91M | $72.91 | 111.55K |
| Q3 2018 | share | Increase | +50.88% | 57.98K shares | 3.82M | $87.52 | 171.95K |
| Q2 2018 | share | Increase | +35.73% | 30K shares | 1.22M | $98.49 | 113.96K |
| Q1 2018 | share | Increase | +42.40% | 25K shares | 2.50M | $119.1 | 83.96K |
| Q4 2017 | share | Increase | +37.80% | 16.17K shares | 2.46M | $127.05 | 58.96K |
| Q3 2017 | share | Decrease | -46.64% | -37.39K shares | -1.36M | $117.49 | 42.79K |
| Q2 2017 | share | Decrease | -38.32% | -49.81K shares | -267K | $79.76 | 80.19K |
| Q1 2017 | share | Decrease | -3.70% | -5K shares | 1.60M | $51.25 | 130K |
| Q4 2016 | share | Increase | +3.85% | 5K shares | -3.75M | $37.44 | 135K |
| Q3 2016 | share | Decrease | -33.33% | -65K shares | -2.00M | $67.78 | 130K |
| Q2 2016 | share | Increase | +56.00% | 70K shares | 2.97M | $55.49 | 195K |
| Q1 2016 | share | Increase | +101.61% | 63K shares | 2.00M | $62.77 | 125K |